Brief: OWC Pharmaceutical Research Received A Permit For A Cannabis Based Ointment Efficacy Trial
05/08/2019 13:17
Aug 5 (Reuters) - OWC Pharmaceutical Research Corp
OWCP.PK :
* OWC PHARMACEUTICAL RESEARCH RECEIVED A PERMIT FOR A
CANNABIS
BASED OINTMENT EFFICACY TRIAL
* OWC PHARMACEUTICAL RESEARCH - ON JULY 18 RECEIVED
APPROVAL FROM
ISRAELI MEDICAL CANNABIS AGENCY TO PERFORM EFFICACY STUDY WITH
OWC TOPICAL OINTMENT
Source text for Eikon: ID:nPn56N2vwa
Further company coverage: OWCP.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OWC Pharmaceutical Research
See all newsAnalysis: U.S. move to loosen vaccine patents will draw drug companies to bargain -lawyers
Analysis: U.S. move to loosen vaccine patents will draw drug companies to bargain -lawyers
Brief: Hemp Inc Signs Letter Of Intent With One World Pharma SAS
Brief: OWC Pharmaceutical Research Received A Permit For A Cannabis Based Ointment Efficacy Trial
Brief: OWC Pharmaceutical Research reports update on multiple myeloma study